CSPC Pharmaceutical Group Files Director List with HKEX
CSPC Pharmaceutical Group Ltd. has filed an updated list of directors with the Hong Kong Stock Exchange. The Board is led by Mr. Cai Dong Chen as Chairman, with Mr. Zhang Cuilong serving as Vice-Chairman and Chief Executive Officer. Other executive directors include Mr. Wang Zhenguo, Mr. Wang Huaiyu, Dr. Li Chunlei, Dr. Yao Bing, Mr. Cai Xin, and Mr. Chen Weiping. The independent non-executive directors are Mr. Wang Bo, Mr. Chen Chuan, Prof. Wang Hongguang, Mr. Au Chun Kwok Alan, Mr. Law Cheuk Kin Stephen, and Ms. Li Quan. In terms of committee memberships, Mr. Cai Dong Chen chairs the Nomination Committee. Mr. Au Chun Kwok Alan chairs both the Audit and Remuneration Committees. Members of the Audit Committee are Mr. Chen Chuan, Mr. Wang Bo, and Mr. Au Chun Kwok Alan. The Nomination Committee includes Mr. Chen Chuan, Mr. Wang Bo, and Ms. Li Quan as members. The Remuneration Committee members are Mr. Chen Chuan, Mr. Wang Bo, and Mr. Au Chun Kwok Alan.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CSPC Pharmaceutical Group Ltd. published the original content used to generate this news brief on November 04, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.